19 May 2013
Keywords: astrazeneca, naropin, gets, new, use, eu, anglo-swedish
Article | 22 December 2003
Anglo-Swedish drug major AstraZeneca's long-acting anesthetic Naropin(ropivacaine) has been approved for a new use in the European Union. The
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2003
17 May 2013
© 2013 thepharmaletter.com